Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Wenn

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Epigenomics|August 10, 2012
Is there a decrease in Keap1 RNA expression in colorectal cancer cells, and is this decrease in expression due to hypermethylation?Ali R Jazirehi, Peter B Wenn, Dylan Arle
Epigenomics|June 14, 2012
UHRF1: a master regulator in prostate cancerAli R Jazirehi, Dylan Arle, Peter B Wenn
American Journal of Cancer Research|April 10, 2012
Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapyAli R Jazirehi, Peter B Wenn, Mohsen Damavand
Epigenomics|August 10, 2012
Does the proliferation of human lymphoma cells depend on the mutation of EZH2 and consequential epigenetic modification of H3K27?Ali R Jazirehi, Dylan Arle, Peter B Wenn
Epigenomics|August 10, 2012
Role of epigenetic modifications of SOX 9 in gastric carcinomaAli R Jazirehi, Dylan Arle, Peter B Wenn
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Epigenomics|August 10, 2012
Is there a decrease in Keap1 RNA expression in colorectal cancer cells, and is this decrease in expression due to hypermethylation?Ali R Jazirehi, Peter B Wenn, Dylan Arle
Epigenomics|June 14, 2012
UHRF1: a master regulator in prostate cancerAli R Jazirehi, Dylan Arle, Peter B Wenn
American Journal of Cancer Research|April 10, 2012
Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapyAli R Jazirehi, Peter B Wenn, Mohsen Damavand
Epigenomics|August 10, 2012
Does the proliferation of human lymphoma cells depend on the mutation of EZH2 and consequential epigenetic modification of H3K27?Ali R Jazirehi, Dylan Arle, Peter B Wenn
Epigenomics|August 10, 2012
Role of epigenetic modifications of SOX 9 in gastric carcinomaAli R Jazirehi, Dylan Arle, Peter B Wenn
Pageof 1